Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-24-273713
Filing Date
2024-12-09
Accepted
2024-12-09 21:33:20
Documents
2
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.ARTAL INTERNATIONAL S.C.A.ARTAL PARTICIPATIONS S.A R.L.INVUS ADVISORS, L.L.C.INVUS GLOBAL MANAGEMENT, LLCINVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.INVUS US PARTNERS LLCMR. AMAURY WITTO

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d882997dsc13da.htm SC 13D/A 274771
2 EX-99.29 d882997dex9929.htm EX-99.29 19282
  Complete submission text file 0001193125-24-273713.txt   296493
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Subject) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60409 | Film No.: 241536933
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 (212) 371-1717
Invus, L.P. (Filed by) CIK: 0001404570 (see all company filings)

EIN.: 830359143
Type: SC 13D/A